One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth Karan BhasinThursday, April 16, 2020 03:50 PM IST
New ‘Advisory Committee’ Under NITI Aayog To Regulate Prices Of Medicines; NPPA Won’t Be Undermined, Says CentreSwarajya StaffTuesday, January 22, 2019 01:54 PM IST
Hindustan Unilever Found Guilty Of Rs 383 Crore Profiteering For Not Passing On GST Rate-Cut Benefits To Customers Swarajya StaffTuesday, December 25, 2018 12:45 PM IST
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign ManufacturersSwarajya StaffFriday, November 16, 2018 12:17 PM IST
Why Modi Government’s Bid To Control Price Of Coronary Stents Hasn’t Yielded Desired ResultM R SubramaniWednesday, August 29, 2018 05:47 PM IST